These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10779856)

  • 1. COMT inhibition in Parkinson's disease: rationale and clinical relevance.
    Deleu D
    Acta Neurol Belg; 2000 Mar; 100(1):5-7. PubMed ID: 10779856
    [No Abstract]   [Full Text] [Related]  

  • 2. COMT inhibitors: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S45-51. PubMed ID: 12211139
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMT inhibitors].
    Bornkessel B
    Med Monatsschr Pharm; 1999 May; 22(5):138-41. PubMed ID: 10365553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment in Parkinson disease].
    Takáts A
    Orv Hetil; 2004 Apr; 145(15):833-4. PubMed ID: 15188639
    [No Abstract]   [Full Text] [Related]  

  • 5. COMT inhibition and safety.
    Martignoni E; Blandini F; Pacchetti C; Nappi G
    Funct Neurol; 2001; 16(4 Suppl):135-40. PubMed ID: 11996508
    [No Abstract]   [Full Text] [Related]  

  • 6. New options for treatment of Parkinson's disease.
    LeWitt PA
    Baillieres Clin Neurol; 1997 Apr; 6(1):109-23. PubMed ID: 9426871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of catechol-O-methyltransferase. Optimizing dopaminergic therapy in idiopathic Parkinson syndrome with entacapone].
    Arnold G; Kupsch A
    Nervenarzt; 2000 Feb; 71(2):78-83. PubMed ID: 10703007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT inhibition with entacapone in the treatment of Parkinson's disease.
    Rinne UK; Gordin A; Teräväinen HT
    Adv Neurol; 1999; 80():491-4. PubMed ID: 10410761
    [No Abstract]   [Full Text] [Related]  

  • 9. Catechol-O-methyltransferase inhibitors: new options for Parkinson's disease.
    Leicht MJ; Mitchell SD
    S D J Med; 1999 Aug; 52(8):295-7. PubMed ID: 10453205
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues important for rational COMT inhibition.
    Dingemanse J
    Neurology; 2000; 55(11 Suppl 4):S24-7; discussion S28-32. PubMed ID: 11147507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease.
    Nutt JG
    Lancet; 1998 Apr; 351(9111):1221-2. PubMed ID: 9643737
    [No Abstract]   [Full Text] [Related]  

  • 12. [COMT inhibition with tolcapone].
    Nervenarzt; 1996 Jul; 67(7 Suppl Comt-hemmu):1-8. PubMed ID: 9404535
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolcapone for Parkinson's disease.
    Med Lett Drugs Ther; 1998 Jun; 40(1028):60-1. PubMed ID: 9629124
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical issues with COMT inhibitors in Parkinson's disease.
    Waters C
    Neurology; 2000; 55(11 Suppl 4):S57-9; discussion S60-4. PubMed ID: 11147511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease.
    Kaakkola S
    Int Rev Neurobiol; 2010; 95():207-25. PubMed ID: 21095464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease.
    Schapira AH; Obeso JA; Olanow CW
    Neurology; 2000; 55(11 Suppl 4):S65-8; discussion S69-71. PubMed ID: 11147512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is new in movement disorders?
    Poewe W
    Wien Klin Wochenschr; 1999 Sep; 111(17):664-71. PubMed ID: 10526391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Entacapone in the therapy of Parkinson disease].
    Teräväinen H
    Duodecim; 1999; 115(24):2734-44. PubMed ID: 11979613
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's disease with COMT inhibitors: tolcapone].
    Avila A; Kulisevsky J
    Neurologia; 1998; 13 Suppl 1():66-71. PubMed ID: 9859687
    [No Abstract]   [Full Text] [Related]  

  • 20. Catechol-0-methyl transferase inhibitors in the treatment of Parkinson's disease.
    Lees AJ
    Neurologia; 1998; 13 Suppl 1():72-5. PubMed ID: 9859688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.